RNS Number : 7846B
Cazenove
21 August 2008
FORM 38.5(a)
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS
WITH RECOGNISED INTERMEDIARY STATUS
DEALING IN A CLIENT-SERVING CAPACITY
(Rule 38.5(a) of the Takeover Code)
1. KEY INFORMATION
Name of exempt principal trader Cazenove
Company dealt in Oxford Biomedica plc
Class of relevant security to which the dealings being Ordinary .01p
disclosed relate (Note 1)
Date of dealing 20thAugust 2008
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of securities Highest price paid Lowest price paid
purchased (Note 3) (Note 3)
25,000 £0.095p £0.095p
Total number of securities Highest price received Lowest price received
sold (Note 3) (Note 3)
25,000 £0.0975p £0.0975p
(b) Derivatives transactions (other than options)
Product name, Long/short Number of securities Price per unit
e.g. CFD (Note 4) (Note 5) (Note 3)
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of securities Exercise price Type, e.g. American, Expiry
date Option
name,e. selling, to which the option European etc.
moneypaid/
g purchasing, relates (Note 5)
received
call varying etc
per unit
option
(Note 3)
(ii) Exercising
Product name, e.g. call option Number of securities Exercise price per unit
(Note 3)
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing
and any other person relating to the voting
rights of any relevant securities under any option referred to on this form or relating to the
voting rights or future acquisition or
disposal of any relevant securities to which any derivative referred to on this form is
referenced. If none, this should be stated.
**************************
**************************
Date of disclosure 21st August 2008
Contact name Barry Page
Telephone number 0207 155 5907
Name of offeree/offeror with Oxford Biomedica plc
which connected
Nature of connection (Note 6) Cazenove are broker and joint financial adviser to Oxford
Biomedica plc
Notes
The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
EMMFKDKBFBKKAFB
|